Bolt Biotherapeutics, Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Bolt Biotherapeutics, Inc. (BOLT) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $375.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2025-03-24
- Bolt Biotherapeutics, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $375.00K, a 92.58% decline from fiscal 2022.
- Bolt Biotherapeutics, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $5.05M.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2023-12-31 | $375.00K 10-K · filed 2025-03-24 |
| 2022-12-31 | $5.05M 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |